指南与共识胸部病理细胞病理与分子病理

ICCR 胸膜、心包和腹膜间皮瘤病理报告推荐

Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
指南 / 共识 · Histopathology · 2023-12-04

国际癌症报告合作组织(ICCR)召集病理学家与肿瘤内科专家,基于证据综述和 2021 年 WHO 分类,制定覆盖胸膜、心包和腹膜间皮瘤的活检与切除标本国际共识数据集,区分「核心」与「非核心」条目,纳入临床、大体、镜下和辅助检测要素,重点讨论原位间皮瘤和肿瘤分级新要求,推荐全球推广以提升报告一致性和数据可比性。

要点

  • 间皮瘤报告应采用 ICCR 国际共识数据集,区分核心与非核心条目。
  • 数据集覆盖所有部位间皮瘤的活检与切除标本,含辅助检测。
  • 新增肿瘤分级要求,并纳入原位间皮瘤等新实体。

核心结论

  • 推荐广泛、一致地实施该数据集,以促进准确报告、增强数据收集一致性、改善流行病学数据比较并支持回顾性研究。

研究设计与样本

  • ICCR 组织国际专家小组(病理学家和一名肿瘤内科医生)基于当前证据批判性回顾和讨论,结合 2021 年 WHO 肿瘤分类变化,制定活检和切除标本的数据条目。

主要发现

  • 文章详述 ICCR 流程和间皮瘤国际共识报告数据集的开发,描述所有部位间皮瘤病理报告应包含的核心和非核心要素,涵盖临床、大体、镜下和辅助检测考虑。

关键数值与推荐

  • 数据集包含核心和非核心要素,涵盖所有部位间皮瘤的活检与切除标本。
  • 评论重点讨论原位间皮瘤等新实体,并提供相关必要辅助检测的背景及肿瘤分级新要求的实施。
  • 所有数据集在 ICCR 网站(www.iccr-cancer.org/data-sets)上全球免费获取。

临床怎么用

  • 病理科医生在间皮瘤活检和切除标本报告中应按照 ICCR 共识数据集区分核心与非核心要素进行结构化报告,并落实肿瘤分级和必要辅助检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Mesothelioma is a rare malignancy of the serosal membranes that is commonly related to exposure to asbestos. Despite extensive research and clinical trials, prognosis to date remains poor. Consistent, comprehensive and reproducible pathology reporting form the basis of all future interventions for an individual patient, but also ensures that meaningful data are collected to identify predictive and prognostic markers. METHODS AND RESULTS: This article details the International Collaboration on Cancer Reporting (ICCR) process and the development of the international consensus mesothelioma reporting data set. It describes the 'core' and 'non-core' elements to be included in pathology reports for mesothelioma of all sites, inclusive of clinical, macroscopic, microscopic and ancillary testing considerations. An international expert panel consisting of pathologists and a medical oncologist produced a set of data items for biopsy and resection specimens based on a critical review and discussion of current evidence, and in light of the changes in the 2021 WHO Classification of Tumours. The commentary focuses particularly upon new entities such as mesothelioma in situ and provides background on relevant and essential ancillary testing as well as implementation of the new requirement for tumour grading. CONCLUSION: We recommend widespread and consistent implementation of this data set, which will facilitate accurate reporting and enhance the consistency of data collection, improve the comparison of epidemiological data, support retrospective research and ultimately help to improve clinical outcomes. To this end, all data sets are freely available worldwide on the ICCR website (www.iccr-cancer.org/data-sets).

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Klebe S, Judge M, Brcic L, et al. Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2023. PMID: 38044849. doi:10.1111/his.15106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。